NO141408C - Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive benzylpyrimidiner - Google Patents
Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive benzylpyrimidinerInfo
- Publication number
- NO141408C NO141408C NO754372A NO754372A NO141408C NO 141408 C NO141408 C NO 141408C NO 754372 A NO754372 A NO 754372A NO 754372 A NO754372 A NO 754372A NO 141408 C NO141408 C NO 141408C
- Authority
- NO
- Norway
- Prior art keywords
- benzylpyrimidines
- preparation
- new therapeutic
- therapeutic active
- analogy procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
- C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
- C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1728774A CH605828A5 (sv) | 1974-12-24 | 1974-12-24 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO754372L NO754372L (sv) | 1976-06-25 |
| NO141408B NO141408B (no) | 1979-11-26 |
| NO141408C true NO141408C (no) | 1980-03-05 |
Family
ID=4424233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO754372A NO141408C (no) | 1974-12-24 | 1975-12-23 | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive benzylpyrimidiner |
Country Status (25)
| Country | Link |
|---|---|
| JP (1) | JPS5191273A (sv) |
| AT (1) | AT344704B (sv) |
| AU (1) | AU500102B2 (sv) |
| BE (1) | BE836996A (sv) |
| BR (1) | BR7508534A (sv) |
| CA (1) | CA1059127A (sv) |
| CH (2) | CH605828A5 (sv) |
| CU (1) | CU34406A (sv) |
| DD (1) | DD123603A5 (sv) |
| DE (1) | DE2558150A1 (sv) |
| DK (1) | DK137797B (sv) |
| ES (1) | ES443790A1 (sv) |
| FI (1) | FI753312A (sv) |
| FR (1) | FR2295750A1 (sv) |
| GB (1) | GB1492140A (sv) |
| HU (1) | HU174324B (sv) |
| IL (1) | IL48416A (sv) |
| LU (1) | LU73971A1 (sv) |
| NL (1) | NL7514269A (sv) |
| NO (1) | NO141408C (sv) |
| PH (1) | PH12314A (sv) |
| PL (1) | PL101046B1 (sv) |
| SE (1) | SE417607B (sv) |
| SU (1) | SU612629A3 (sv) |
| ZA (1) | ZA756964B (sv) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR71725B (sv) * | 1977-11-10 | 1983-06-22 | Hoffmann La Roche | |
| US9567318B2 (en) | 2009-08-17 | 2017-02-14 | Memorial Sloan-Kettering Cancer Center | Substituted pyrimidine compounds and uses thereof |
| KR102461419B1 (ko) | 2014-05-13 | 2022-11-02 | 메모리얼 슬로안 케터링 캔서 센터 | Hsp70 조정물질 및 이의 제조 및 이용 방법 |
-
1974
- 1974-12-24 CH CH1728774A patent/CH605828A5/xx not_active IP Right Cessation
-
1975
- 1975-11-04 IL IL48416A patent/IL48416A/xx unknown
- 1975-11-05 ZA ZA00756964A patent/ZA756964B/xx unknown
- 1975-11-07 AU AU86433/75A patent/AU500102B2/en not_active Expired
- 1975-11-25 FI FI753312A patent/FI753312A/fi not_active Application Discontinuation
- 1975-11-29 CU CU7534406A patent/CU34406A/es unknown
- 1975-12-08 NL NL7514269A patent/NL7514269A/xx not_active Application Discontinuation
- 1975-12-09 LU LU73971A patent/LU73971A1/xx unknown
- 1975-12-18 CA CA242,038A patent/CA1059127A/en not_active Expired
- 1975-12-19 HU HU75HO1864A patent/HU174324B/hu unknown
- 1975-12-22 JP JP50152026A patent/JPS5191273A/ja active Pending
- 1975-12-22 FR FR7539341A patent/FR2295750A1/fr active Granted
- 1975-12-22 AT AT975975A patent/AT344704B/de not_active IP Right Cessation
- 1975-12-22 BR BR8534/75A patent/BR7508534A/pt unknown
- 1975-12-22 SU SU752301512A patent/SU612629A3/ru active
- 1975-12-22 PH PH7517896A patent/PH12314A/en unknown
- 1975-12-23 NO NO754372A patent/NO141408C/no unknown
- 1975-12-23 DD DD190511A patent/DD123603A5/xx unknown
- 1975-12-23 SE SE7514642A patent/SE417607B/sv unknown
- 1975-12-23 DE DE19752558150 patent/DE2558150A1/de not_active Ceased
- 1975-12-23 GB GB52604/75A patent/GB1492140A/en not_active Expired
- 1975-12-23 PL PL1975185924A patent/PL101046B1/pl unknown
- 1975-12-23 ES ES443790A patent/ES443790A1/es not_active Expired
- 1975-12-23 BE BE163041A patent/BE836996A/xx unknown
- 1975-12-23 DK DK589675AA patent/DK137797B/da unknown
-
1977
- 1977-12-07 CH CH1499977A patent/CH617191A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE2558150A1 (de) | 1976-07-01 |
| DK137797B (da) | 1978-05-08 |
| DK137797C (sv) | 1978-10-16 |
| BR7508534A (pt) | 1976-12-21 |
| DK589675A (sv) | 1976-06-25 |
| AU500102B2 (en) | 1979-05-10 |
| NO141408B (no) | 1979-11-26 |
| FR2295750B1 (sv) | 1980-06-20 |
| IL48416A (en) | 1980-02-29 |
| PH12314A (en) | 1979-01-16 |
| ES443790A1 (es) | 1977-12-16 |
| PL101046B1 (pl) | 1978-11-30 |
| BE836996A (fr) | 1976-06-23 |
| NO754372L (sv) | 1976-06-25 |
| DD123603A5 (sv) | 1977-01-05 |
| AU8643375A (en) | 1977-05-12 |
| FI753312A (sv) | 1976-06-25 |
| SE417607B (sv) | 1981-03-30 |
| IL48416A0 (en) | 1976-01-30 |
| ZA756964B (en) | 1976-10-27 |
| FR2295750A1 (fr) | 1976-07-23 |
| AT344704B (de) | 1978-08-10 |
| ATA975975A (de) | 1977-12-15 |
| HU174324B (hu) | 1979-12-28 |
| CH617191A5 (en) | 1980-05-14 |
| CA1059127A (en) | 1979-07-24 |
| CU34406A (es) | 1978-09-08 |
| CH605828A5 (sv) | 1978-10-13 |
| JPS5191273A (sv) | 1976-08-10 |
| GB1492140A (en) | 1977-11-16 |
| SE7514642L (sv) | 1976-06-28 |
| SU612629A3 (ru) | 1978-06-25 |
| LU73971A1 (sv) | 1977-07-01 |
| NL7514269A (nl) | 1976-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO143576C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser | |
| NO141407C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivater | |
| NO143460C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner. | |
| NO141800C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner. | |
| NO144455C (no) | Fremgangsmaate ved fremstilling av terapeutisk aktive nye piperidinderivater. | |
| NO148848C (no) | Analogifremgangsmaate ved fremstilling av nye antibiotisk aktive spiroimidazolidin-rifamyciner | |
| NO144740C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk virksomme, substituerte n-(1-benzyl-pyrrolidinyl-2-alkyl)-benzamider | |
| NO142865C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive karbazoler | |
| NO145791C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive imidazolderivater | |
| NO142838C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater | |
| NO143064C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner | |
| NO144108C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-benzylpiperid-4-yl)-benzamider | |
| NO146497C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 2-anilino-oxazoliner | |
| NO143664C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive dibenzofuranforbindelser | |
| NO142077C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-cyclohexyl-3-pyrrolidinyl)-benzamider | |
| NO147485C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-aminomethylisoflavonderivater | |
| NO145238C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater | |
| NO144039C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk virksomme benzofuranderivater | |
| NO144704C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-alkyl-2-(fenoksymetyl)-5-nitro-imidazoler | |
| NO141441C (no) | Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av isoindolin-1-on | |
| NO146672C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cinnolinderivater | |
| NO143844C (no) | Analogifremgangsmaate til fremstilling av nye terapeutisk aktive disubstituerte fenoletere av 3-amino-2-hydroksypropan | |
| NO141408C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive benzylpyrimidiner | |
| NO144019C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive naftyridinderivater | |
| NO145538C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive morfantridin-forbindelser |